Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]
Larimar Therapeutics (LRMR) had its price target raised by Wedbush from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed? [Yahoo! Finance]
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering